Cargando…
Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
‘Value-based’ outcomes, pricing, and reimbursement are widely discussed as health sector reforms these days. In this paper, we discuss their meaning and relationship in the context of personalized healthcare, defined as receipt of care conditional on the results of a biomarker-based diagnostic test....
Autores principales: | Garrison, Louis P., Towse, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618156/ https://www.ncbi.nlm.nih.gov/pubmed/28869571 http://dx.doi.org/10.3390/jpm7030010 |
Ejemplares similares
-
Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned
por: Towse, Adrian, et al.
Publicado: (2013) -
Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service
por: Russo, Pierluigi, et al.
Publicado: (2022) -
Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983) -
The introduction of a value‐based reimbursement programme—Alignment and resistance among healthcare providers
por: Eriksson, Thérèse, et al.
Publicado: (2022) -
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?
por: Zamora, Bernarda, et al.
Publicado: (2021)